Ticker Launch
Sign inTry it free

SPAC · Merger completed

Alpha Healthcare Acquisition Corp. III

Business combination with Carmell Therapeutics Corporation

Alpha Healthcare Acquisition Corp. III is a blank-check company (SPAC) that raised $150M in its initial public offering on Jul 27, 2021, listing on Nasdaq Capital Market. It completed its business combination with Carmell Therapeutics Corporation on Jul 14, 2023; the combined company is Carmell Corporation (CTCX). McKinsey & Company led the IPO. Goodwin Procter advised the SPAC and Latham & Watkins advised the underwriters on the IPO.

Carmell Therapeutics Corporation is a Phase 2 stage biotechnology company developing allogeneic plasma-based biomaterials for bone and soft tissue indications. Its Phase 2 trial studies accelerated healing and reduced infections in open tibia fractures, and a foot and ankle fusion trial is planned.

Status
Merger completed
IPO date
Jul 27, 2021
IPO size
$150M
IPO exchange
Nasdaq Capital Market
Target
Carmell Therapeutics Corporation
Announced
Jan 4, 2023
Closed
Jul 14, 2023
Combined company
Carmell Corporation (CTCX)
IPO underwriters
McKinsey & Company
SPAC counsel (IPO)
Goodwin Procter
Underwriters' counsel (IPO)
Latham & Watkins

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2023